1. Home
  2. UE vs IMNM Comparison

UE vs IMNM Comparison

Compare UE & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban Edge Properties of Beneficial Interest

UE

Urban Edge Properties of Beneficial Interest

HOLD

Current Price

$20.76

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.58

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UE
IMNM
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UE
IMNM
Price
$20.76
$23.58
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$22.00
$32.10
AVG Volume (30 Days)
964.6K
1.7M
Earning Date
02-11-2026
03-18-2026
Dividend Yield
3.67%
N/A
EPS Growth
23.73
N/A
EPS
0.74
N/A
Revenue
$471,935,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.53
P/E Ratio
$27.96
N/A
Revenue Growth
6.06
N/A
52 Week Low
$15.66
$5.15
52 Week High
$21.87
$27.65

Technical Indicators

Market Signals
Indicator
UE
IMNM
Relative Strength Index (RSI) 65.97 48.17
Support Level $20.71 $24.03
Resistance Level $21.30 $27.65
Average True Range (ATR) 0.52 1.54
MACD 0.18 -0.32
Stochastic Oscillator 65.35 13.27

Price Performance

Historical Comparison
UE
IMNM

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: